3028124-poster-p-dna
FIRST
DRUG in the world
approved to treat
Favipiravir-based
COVID-19

HBV is the leading cause of cancer-related morbidity and mortality worldwide

3028124-poster-p-dna
Digital illustration of dna
First ORAL drug
APPROVED to treat
COVID-19
Digital illustration of dna
shutterstock_360472571-scientist
AVIFAVIR delivered to
over 200,000 patients
& 16 countries worldwide
shutterstock_360472571-scientist

Compas

12760 High Bluff Dr., San Diego, CA, 92130

Contact

 bottle

CHR101 has the potential to eradicate HBV and to cure chronically infected HBV patients

 

Calendar

Learn more about our news and events in 2020

 Events